Last reviewed · How we verify
NCT06882044: Mobileapp
The Effect of a Mobile Application in Patients With Acute Myocardial Infarction
NA trial testing mHealth in Acute Myocardial Infarction (AMI) in 61 participants. Completed in 10 July 2024.
10 July 2024
Quick facts
| Lead sponsor | Trakya University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 61 |
| Start date | 1 November 2021 |
| Primary completion | 10 July 2024 |
| Estimated completion | 10 July 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- mHealth
Conditions studied
- Acute Myocardial Infarction (AMI) — all drugs for Acute Myocardial Infarction (AMI) →
- Mobile Health Technology (mHealth) — all drugs for Mobile Health Technology (mHealth) →
- Quality of Lifte — all drugs for Quality of Lifte →
- Treatment Adherence — all drugs for Treatment Adherence →
Sponsor
Trakya University
Who can join
19 and older, any sex, with Acute Myocardial Infarction (AMI) or Mobile Health Technology (mHealth). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background and Aim: Acute myocardial infarction is a clinical condition with high mortality and morbidity rates. Ensuring patient adherence to treatments and lifestyle recommendations after discharge is crucial for effective post-acute myocardial infarction management. This study aimed to determine the impact of a mobile application on treatment adherence, self-management, and quality of life in patients with acute myocardial infarction undergoing primary percutaneous coronary ıntervention. Material and Methods: This randomized controlled and experimental study was conducted between 2021 and 2024 at the cardiology clinic of a university hospital. It included patients who had their first time with ST-segment elevation acute myocardial infarction and underwent primary percutaneous coronary intervention (n=31/30). The control group was provided standard discharge education with the "Educational Booklet for Patients Who Have Had a Heart Attack". The intervention group, in addition to these practices, mobile application support was provided. They were followed up for 6 months post-discharge. Data were collected at 1, 3 and 6 months. The patient information form including characteristics related to lifestyle changes, Medication Adherence Reporting Scale (MARS), and Myocardial Infarction Dimensional Assessment Scale (MIDAS) were used in data collection.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06882044
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of mHealth
Trials testing the same drug.
- NCT06921798 — Remote Resilience: Novel Applications of mHealth in Nicaragua's Cancer Control Program · NA · not yet recruiting
- NCT06499064 — EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM) · NA · not yet recruiting
- NCT06594328 — Effect of Text Message Interventions in Maintaining Gingival Health in Pregnant Women · NA · enrolling by invitation
- NCT06535867 — The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorde · recruiting
- NCT06409793 — Motivating Adolescent Fitness · NA · not yet recruiting
Other recruiting trials for Acute Myocardial Infarction (AMI)
Currently open trials in the same condition.
- NCT07400601 — A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at Zhongshan Hospital · recruiting
- NCT07208006 — Very Early PCSK9 Inhibition for Acute Myocardial Infarction · NA · recruiting
- NCT07537296 — Coronary and Myocardial Evaluation by Cardiac CT for Acute Myocardial Infarction · recruiting
- NCT07276282 — Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction · Phase 3 · recruiting
- NCT07293923 — Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock · NA · recruiting
Other Trakya University trials
Trials by the same sponsor.
- NCT07443735 — Pinwheel and Bubble Blowing for Pain and Emotional Responses in Children · NA · not yet recruiting
- NCT07464795 — The Effects of Kinesio Taping on Heel-Rise Endurance and Gastrocnemius Muscle Oxygenation in Healthy Young Adults · NA · not yet recruiting
- NCT07421687 — 3D Volumetric Plaque Assessment on Teeth, Composite Restorations, and Ceramic Veneers Using an Intraoral Scanner · not yet recruiting
- NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
- NCT07349056 — Early Effects of Orthognathic Surgery on Periodontal Phenotype: A 6-Month Prospective Clinical and Radiographic Evaluati · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06882044 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Trakya University
- Last refreshed: 18 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06882044.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing